AtkinsRéalis Group (ATRL) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Nov, 2025Executive summary
Achieved record organic revenue growth and record-high backlog, with total services revenue up 12% to $2.5 billion and strong performance in Nuclear and Linxon segments.
Nuclear revenue grew 77% year-over-year to a record $538 million, and Linxon revenue increased 36%, both contributing to significant EBIT gains.
Segment-adjusted EBIT for services rose 20% to $224 million; positive operating cash flow of $39 million and leverage ratio at 1.1x.
Backlog reached a record $20.4 billion, up 31% year-over-year, with notable growth in Nuclear and Linxon.
Announced sale of Highway 407 interest and completed acquisition of David Evans, expanding U.S. footprint and workforce to 40,000.
Financial highlights
Total revenues increased 12% year-over-year to $2.5 billion in Q1 2025; organic revenue growth was 10%.
Net income attributable to shareholders rose 50% to $69 million; diluted EPS up 50% to $0.39.
Adjusted EPS from PS&PM increased to $0.57 per diluted share; adjusted net income from PS&PM grew 36% to $100.5 million.
Free cash flow was negative $14 million after CapEx and lease payments; net cash from operating activities was $39 million.
Net limited recourse and recourse debt to Adjusted EBITDA ratio improved to 1.1 from 1.7 a year ago.
Outlook and guidance
Raised full-year Nuclear revenue outlook to $1.9–2.0 billion for 2025, with annual Nuclear revenue target of $2.2–2.5 billion by 2027.
Nuclear adjusted EBIT to gross revenue ratio revised to 11–13% for 2025.
Engineering Services organic revenue growth guidance maintained at 7–9% for 2025; segment-adjusted EBITDA margin expected at 16–17%.
Operating cash flow for 2025 expected to exceed $300 million, weighted to the second half.
2025–2027 targets: Engineering Services organic revenue CAGR >8%, EBITDA margin 17–18%.
Latest events from AtkinsRéalis Group
- Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 202527 Feb 2026 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 20243 Feb 2026 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight Q2 2024.ATRL
Q2 20241 Feb 2026 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 202414 Jan 2026 - Record 2024 revenue, backlog, and $2.8B asset sale set up growth and margin gains for 2025.ATRL
Q4 20242 Dec 2025 - Q2 2025 saw record backlog, 15% revenue growth, and a $2.32B net income surge.ATRL
Q2 202523 Nov 2025 - Q3 2025 saw double-digit revenue and EPS growth, record backlog, and raised Nuclear guidance.ATRL
Q3 202513 Nov 2025